p53 tumor suppressor gene protein expression in cervical cancer: relationship to prognosis

By Bremer G.L.   Tieboschb A.T.M.G.   van der Putten H.W.H.M.   de Haan J.   Arends J.-W.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 63, Iss. 1, 1995-11 ,pp. : 55-59

Elsevier

Access to resources Recommend Favorite

Day 3 morphology is a poor predictor of blastocyst quality in extended culture

By Graham J.   Han T.   Porter R.   Levy M.   Stillman R.   Tucker M.J.  

Fertility and Sterility, Vol. 74, Iss. 3, 2000-09 ,pp. : 495-497

Elsevier

Access to resources Recommend Favorite

HPV testing and visual inspection for cervical cancer screening in resource-poor regions

By Jeronimo J.   Castle P.E.   Herrero R.   Burk R.D.   Schiffman M.  

International Journal of Gynecology and Obstetrics, Vol. 83, Iss. 3, 2003-12 ,pp. : 311-313

Elsevier

Access to resources Recommend Favorite

Expression and localization of maspin in cervical cancer and its role in tumor progression and lymphangiogenesis

By Liu Zhiqiang   Shi Yangyang   Meng Wei   Liu Yufang   Yang Kaixuan   Wu Shuhua   Peng Zhilan  

Archives of Gynecology and Obstetrics, Vol. 289, Iss. 2, 2014-02 ,pp. : 373-382

Springer Publishing Company

Access to resources Recommend Favorite

Poor clinical outcome in early stage cervical cancer with human papillomavirus-18 positive lymph nodes

By Sapy T.   Hernadi Z.   Konya J.   Lukacsko L.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 90, Iss. 1, 2000-05 ,pp. : 93-95

Elsevier

Access to resources Recommend Favorite